The enhancements in neurostimulation technology, which provides relief from chronic pain, will be unveiled.
NeuroMetrix is coming to the 2016 International Consumer Electronics Show. NeuroMetrix will unveil the next generation of its Quell Wearable Therapy Platform. The presentation by NeuroMetrix will take place on the 10th of December, 2016.
How To: Buy a Pokemon Go Plus
According to NeuroMetrix their Quell technology has been innovated. The innovative enhancements to Quell Wearable Pain Relief Technology will be unveiled at CES 2016.
CES has been a successful platform for consumer technology for the last 50 years. So its fair attendees receive their first glimpse of the latest generation of Quell technology at CES.
The Quell wearable will be displayed at the Booth # 73313 in the Digital Health section of CES. NeuroMetrix is also part of the exclusive group which will official press event of CES. The press event called CES Unveiled will take place on the 4th of January 2016.
According to NeuroMetrix they are excited to participate again in CES. NeuroMetrix will also unveil their innovative functionality, smartphone integration, and digital health features. The improvements to Quell products make it the most advanced consumer wearable therapeutic.
Quell employs the patented neurostimulation technology by NeuroMetrix. The wearable technology by Quell provides widespread relief from chronic pain.
The wearable devices are lightweight and can be worn during daytime and at night. The devices can also be worn while active. Studies have shown Quell customers have experienced 81% reduction in pain levels.
67% of patients have reported reduction of pain medication usage. The Quell app also automatically tracks and personalizes pain therapy. Quell was also one of four finalists at the Best of CES 2015 award in Health and Fitness.
Don't Miss: iPhone 8: Everything You Need to Know
“We are excited to participate again in CES and to reveal the new innovative functionality, smartphone integration, and digital health features that are being added to Quell,” said, Shai N. Gozani, M.D., Ph.D. “These improvements will further solidify Quell as the most advanced consumer wearable therapeutic on the market.”